Certolizumab Pegol Plus Methotrexete Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis.

Abstract

Certolizumab Pegol Plus Methotrexete Is Significantly More Effective Than Placebo Plus Methotrexate in Active Rheumatoid Arthritis

Keywords

• rheumatoid arthritis
• biologic therapy